| __timestamp | Alnylam Pharmaceuticals, Inc. | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 50561000 | 27632226 |
| Thursday, January 1, 2015 | 41097000 | 97707000 |
| Friday, January 1, 2016 | 47159000 | 129037000 |
| Sunday, January 1, 2017 | 76545000 | 151332000 |
| Monday, January 1, 2018 | 73106000 | 158719000 |
| Tuesday, January 1, 2019 | 194688000 | 170104000 |
| Wednesday, January 1, 2020 | 414801000 | 192195000 |
| Friday, January 1, 2021 | 704143000 | 220706000 |
| Saturday, January 1, 2022 | 868601000 | 204426000 |
| Sunday, January 1, 2023 | 1517886000 | 133788000 |
Unveiling the hidden dimensions of data
In the dynamic world of biotechnology, financial performance is a key indicator of a company's health and potential. Alnylam Pharmaceuticals and Travere Therapeutics, two prominent players in the industry, have shown distinct trajectories in their gross profit trends over the past decade. From 2014 to 2023, Alnylam Pharmaceuticals experienced a remarkable growth, with its gross profit surging by over 2,900%, peaking in 2023. This growth reflects Alnylam's successful product launches and strategic market positioning. In contrast, Travere Therapeutics displayed a more modest increase of approximately 384% during the same period, highlighting steady progress but at a slower pace. The year 2023 marked a significant divergence, with Alnylam's gross profit reaching nearly 11 times that of Travere's. These trends underscore the varying strategies and market responses of these companies, offering valuable insights for investors and industry analysts.
Vertex Pharmaceuticals Incorporated and Travere Therapeutics, Inc.: A Detailed Gross Profit Analysis
Alnylam Pharmaceuticals, Inc. and Dr. Reddy's Laboratories Limited: A Detailed Gross Profit Analysis
Gross Profit Comparison: Alnylam Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc. Trends
Gross Profit Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Alkermes plc
Gross Profit Comparison: Alnylam Pharmaceuticals, Inc. and Veracyte, Inc. Trends
Gross Profit Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Vericel Corporation
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or Ligand Pharmaceuticals Incorporated
Gross Profit Trends Compared: Jazz Pharmaceuticals plc vs Travere Therapeutics, Inc.
Who Generates Higher Gross Profit? Lantheus Holdings, Inc. or Travere Therapeutics, Inc.
Who Generates Higher Gross Profit? Amneal Pharmaceuticals, Inc. or Travere Therapeutics, Inc.
Perrigo Company plc vs Travere Therapeutics, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Veracyte, Inc. and Travere Therapeutics, Inc.